Form 4 for BDSX BIODESIX INC
Accepted 2022-12-22 00:00:00 ET · period of report 2022-12-21 · accession 0001140361-22-046669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-22 | 2022-12-21 | BDSX | Kayyem Jon Faiz | Dir | M - OptEx | — | +31.6K | 31.6K | New | — |
| D | 2022-12-22 | 2022-12-21 | BDSX | Kayyem Jon Faiz | Dir | M - OptEx | $0.00 | -31.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-21 | M | A | 31,619 | — | 31,619 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-12-21 | M | D | 31,619 | $0.00 | 0 | D | — · — to — | 31,619 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) These restricted stock units vested in full on December 5, 2022 and were settled in shares of Common Stock on December 21, 2022. These restricted stock units had no expiration date. |